Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNA
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, it is important to note that T7 RNAP has cryptic RNA-templated transcription capabilities, resulting in the formation of different types of dsRNA byproducts, including long antisense–sense dsRNA,7,8 3′-heterogeneity, and 3′-loopback dsRNA.9”
From Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses (2024) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728
Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930
Karikó, K., Muramatsu, H., Ludwig, J., & Weissman, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr695 · Cited by 898 · cited 1×
“It was not unusual to observe that mRNA samples with reduced dsRNA byproducts triggered less immunostimulatory response and more protein expression based on previous reports.(9,12) A possible explanation could be that dsRNA induced protein kinase R (PKR) activation, inhibiting translation of the mRNA by phosphorylatin…”
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq347 · Cited by 682
A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA
Baiersdörfer, M., Boros, G., Muramatsu, H., Mahiny, A., Vlatkovic, I., Sahin, U., & Karikó, K. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.018 · Cited by 569
Impact of mRNA chemistry and manufacturing process on innate immune activation
Nelson, J., Sorensen, E. W., Mintri, S., Rabideau, A. E., Zheng, W., Besin, G., Khatwani, N., Su, S. V., Miracco, E. J., Issa, W. J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz6893 · Cited by 354
Vaidyanathan, S., Azizian, K. T., Haque, A. K. M. A., Henderson, J. M., Hendel, A., Shore, S., Antony, J. S., Hogrefe, R. I., Kormann, M. S. D., Porteus, M. H., et al. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.06.010 · Cited by 262
An origin of the immunogenicity of in vitro transcribed RNA
Mu, X., Greenwald, E., Ahmad, S., & Hur, S. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky177 · Cited by 218
HPLC purification of in vitro transcribed long RNA
Weissman, D., Pardi, N., Muramatsu, H., & Karikó, K. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_3 · Cited by 180 · cited 1×
“dsRNA dot blot was performed according to a previous publication.(10) Dot blot was visualized on GE Amersham Imager 680.”
Research works printed but not linked: 16
- Fortner, 2021, First COVID-19 vaccines receiving the US FDA and EMA emergency use authorization, Discoveries, 9, e122, 10.15190/d.2021.1 · DOI
- Jhaveri, 2021, The COVID-19 mRNA vaccines and the pandemic: do they represent the beginning of the end or the end of the beginning?, Clin. Ther., 43, 549, 10.1016/j.clinthera.2021.01.014 · DOI
- Kalmakoff, 1973, A simple method for the separation of single-stranded and double-stranded RNA on hydroxyapatite, Anal. Biochem., 55, 26, 10.1016/0003-2697(73)90287-X · doi:10.1016/0003-2697(73)90287-x
- Foster, 2019, Purification of mRNA encoding chimeric antigen receptor is critical for generation of a robust T-cell response, Hum. Gene Ther., 30, 168, 10.1089/hum.2018.145 · DOI · Paper page
- Kanwal, 2018, Large-scale in vitro transcription, RNA purification and chemical probing analysis, Cell. Physiol. Biochem., 48, 1915, 10.1159/000492512 · DOI
- Wu, 2020, Synthesis of low immunogenicity RNA with high-temperature in vitro transcription, RNA, 26, 345, 10.1261/rna.073858.119 · DOI · Paper page
- Gholamalipour, 2019, Efficient inhibition of RNA self-primed extension by addition of competing 3’-capture DNA-improved RNA synthesis by T7 RNA polymerase, Nucleic Acids Res., 47, e118, 10.1093/nar/gkz700 · DOI
- Cavac, 2021, High-salt transcription of DNA cotethered with T7 RNA polymerase to beads generates increased yields of highly pure RNA, J. Biol. Chem., 297, 100999, 10.1016/j.jbc.2021.100999 · DOI
- Triana-Alonso, 1995, Self-coded 3′-extension of run-off transcripts produces aberrant products during in vitro transcription with T7 RNA polymerase, J. Biol. Chem., 270, 6298, 10.1074/jbc.270.11.6298 · DOI · Paper page
- Gholamalipour, 2018, 3’ end additions by T7 RNA polymerase are RNA self-templated, distributive and diverse in character-RNA-Seq analyses, Nucleic Acids Res., 46, 9253, 10.1093/nar/gky796 · DOI · Paper page
- Nacheva, 2003, Preventing nondesired RNA-primed RNA extension catalyzed by T7 RNA polymerase, Eur. J. Biochem., 270, 1458, 10.1046/j.1432-1033.2003.03510.x · DOI · Paper page
- Moqtaderi, 2014, Secondary structures involving the poly(A) tail and other 3’ sequences are major determinants of mRNA isoform stability in yeast, Microb. Cell, 1, 137, 10.15698/mic2014.04.140 · DOI
- Milligan, 1987, Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates, Nucleic Acids Res., 15, 8783, 10.1093/nar/15.21.8783 · DOI · Paper page
- Martin, 1988, Processivity in early stages of transcription by T7 RNA polymerase, Biochemistry, 27, 3966, 10.1021/bi00411a012 · DOI · Paper page
- Huang, 2000, Misincorporation by wild-type and mutant T7 RNA polymerases: identification of interactions that reduce misincorporation rates by stabilizing the catalytically incompetent open conformation, Biochemistry, 39, 11571, 10.1021/bi000579d · DOI
- Balachandran, 2000, Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection, Immunity, 13, 129, 10.1016/S1074-7613(00)00014-5 · DOI · Paper page
Cited by
Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses
Camperi, J., Roper, B., Freund, E., Leylek, R., Nissenbaum, A., Galan, C., Caothien, R., Hu, Z., Ko, P., Lee, A., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04162 · Cited by 22
Metadata
- Authors
- Piao, X., Yadav, V., Wang, E., Chang, W., Tau, L., Lindenmuth, B. E., & Wang, S. X.
- Venue
- Molecular Therapy - Nucleic Acids
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 29
- Pages
- 618-624
- ISSN
- 2162-2531
- Cited by
- 79
- References
- 11
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Ultragenyx Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNA. https://app.cochat.ai/papers/10.1016/j.omtn.2022.08.001
- The paper
- Piao, X., Yadav, V., Wang, E., Chang, W., Tau, L., Lindenmuth, B. E., & Wang, S. X. (2022). Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNA. Molecular Therapy - Nucleic Acids. https://doi.org/10.1016/j.omtn.2022.08.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.